Article

Retinal endovascular surgery helps those with CRVO, HRVO

Fort Lauderdale, FL-Vitrectomy with retinal vein cannulation and infusion of tissue plasminogen activator (t-PA) is a relatively safe procedure that improves vision in patients with central retinal vein occlusion (CRVO) or hemispheric retinal vein occlusion (HRVO), according to Jeffrey N. Weiss, MD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
© 2025 MJH Life Sciences

All rights reserved.